OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Miia Kivipelto

3 Projects | 1 Researchers | $4,267,495 Invested

2024

FINGERS Brain Health Institute

Miia Kivipelto, MD, PhD

Strategic Collaborative Framework for developing and testing innovative combination therapies, biomarkers, and digital solutions for precision prevention of cognitive decline and Alzheimer’s Disease and Related Dementias (previously: FINGERS Brain Health Institute - ADDF Memorandum of Understanding Planning Grant)

  • Funding Amount: $218,375
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Vascular
  • Status: Active

2022

FINGERS Brain Health Institute

Miia Kivipelto, MD, PhD

2021 Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery to support parts of the ground-breaking MET-FINGER clinical trial and other WW-FINGERS related research and dissemination activities

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Status: Active

2020

Imperial College London

Miia Kivipelto, MD, PhD

MET-FINGER-APOE: A randomized controlled trial of multimodal lifestyle intervention and metformin to prevent cognitive impairment and disability in a cognitively healthy APOE4 enriched at-risk population

  • Funding Amount: $3,899,120
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: Other
  • Status: Active